Skip to main content

Advertisement

Table 1 Clinical and laboratory features along with rK39 results of patients with visceral Leishmaniasis and Controls

From: The rK39 strip test is non-predictor of clinical status for kala-azar

Study entry
  VL patients Controls
  Pre-treated Post-treated (180 day)  
No. 100 50 110
Age (years) 26 ± 4.5 - 27 ± 4.1
Duration of illness (months) 4.4 ± 0.45 - -
Weight (kg) 40.1 ± 6.6 45.4 ± 5.2 60 ± 5.4
Karnofsky score 71.8 ± 2.5 85.4 ± 2.7 100
Spleen size(cm) 8.4 ± 2.4 4.0 ± 0.6 -
Splenic aspirate score 2.9 ± 0.4 - -
WBC count(× 103/mm3) 3.49 ± 0.59 6.4 ± 0.6 9.1 ± 2.3
Hemoglobin (g/dL) 6.9 ± 0.48 11.2 ± 0.76 14.2 ± 2.1
Platelet count(× 103/mm3) 72 ± 0.35 270 ± 0.5 254 ± 23
rK39 positivity 98* 50* 5*
  1. *indicates total no. of positive.